Dow Jones

42,909.58

-0.96%

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
USOTC
Bionik Laboratories Corporation (CE) (BNKL)
Bionik Laboratories Corporation (CE) (BNKL) Noticias

BNKL

Bionik Laboratories (CE) (BNKL)

Bionik Laboratories Corporation (CE)

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:BNKL

1 2 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
30/06/2023	15:31	Edgar (US Regulatory)	Form 15-12G - Securities registration termination [Section 12(g)]	USOTC:BNKL	Bionik Laboratories Corporation (CE)
21/06/2023	16:05	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
21/06/2023	09:59	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
16/06/2023	07:56	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
08/02/2023	07:02	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
07/12/2022	10:29	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
07/12/2022	10:27	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
04/11/2022	15:32	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
25/10/2022	10:28	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
27/05/2022	12:31	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
01/06/2020	13:17	Edgar (US Regulatory)	Specialized Disclosure Report (sd)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
21/02/2020	16:12	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
13/02/2020	11:17	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
13/11/2019	05:01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
12/11/2019	14:58	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
28/10/2019	09:05	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
16/09/2019	16:26	Edgar (US Regulatory)	Securities Registration Statement (s-1)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
18/03/2019	05:05	Edgar (US Regulatory)	Withdrawal of Registration Statement (rw)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
11/02/2019	15:21	Edgar (US Regulatory)	Seperately Filed Delaying Amendment Under Securities Act Rule 473 to Delay Effectiveness of a 1933 Act Registration Statement...	USOTC:BNKL	Bionik Laboratories Corporation (CE)
16/10/2018	16:24	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
17/08/2018	16:15	Edgar (US Regulatory)	Information Statement - All Other (definitive) (def 14c)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
10/08/2018	16:11	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
07/08/2018	16:36	Edgar (US Regulatory)	Proxy Statement - Other Information (preliminary) (pre 14c)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
15/06/2018	13:38	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (3/a)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
05/10/2017	16:27	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
05/10/2017	13:30	Edgar (US Regulatory)	Revised Proxy Soliciting Materials (definitive) (defr14a)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
03/08/2017	16:29	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
14/07/2017	16:29	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
12/07/2017	15:27	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
30/06/2017	16:08	Edgar (US Regulatory)	Amended Tender Offer Statement by Issuer (sc To-i/a)	USOTC:BNKL	Bionik Laboratories Corporation (CE)